Singapore has one of the world’s highest vaccination rates with 80 per cent of its population receiving their full two doses of the COVID-19 vaccine. While they are safe and effective, side effects of the jab may differ from person to person. Some recipients may experience little or no side effects, while others may experience serious adverse reactions. The efficacy and the side effects of vaccines may be associated with the health of the patient’s gut and immunity.
The gut is widely regarded as “the second brain” and is one of the most important organs in the body, accommodating approximately 70% of our immune cells. A healthy gut contains beneficial gut bacteria and immune cells that ward off infectious agents such as bad bacteria and viruses. The gut microbiome may also stimulate the brain to produce chemicals and communicating with the nerves connected to it (i.e., gut-brain axis, GBA).
It is quite clear that the gut’s primary function is the digestion of food, absorption of nutrients and the excretion of waste. However, the fact is that the gut can do more than we think. Roughly 100 trillion bacteria reside within and they produce metabolites that have effects on our health. Its key functions relate to metabolism, immune system regulation, and protection against pathogen invasion. Its microbiome plays an essential role in the health of a human being, though they are sensitive and their harmonious communities can be easily be disturbed. When “dysbiosis” is present, (i.e., insufficient beneficial bacteria, an overgrowth of bad bacteria, and perhaps even a low diversity of species within the microbiome) it can impact severity and persistent symptoms of COVID-19, and the risk of intestinal inflammation and other associated diseases such as obesity, diabetes, autism and colorectal cancer (CRC) increases. Thus, having a healthy gut microbiome is essential for overall health.
G-NiiB ‘Immunity +’ is a unique microbiome immunity formula containing live freeze-dried ‘good’ bacteria with patented microencapsulation technology from Italy, and heat-resistant prebiotics to replenish beneficial microbes in the human gut. Using our proprietary database of over 10,000 subjects, big data analysis and machine learning algorithms, G-NiiB Immunity+ was formulated with an optimized 3+3 best ratio of live good bacteria and prebiotics to provide the BEST result and achieve our health goal.
G-NiiB has obtained exclusive patent* licensing from the Chinese University of Hong Kong. G-NiiB is a trademark of GenieBiome, a leading microbiome biotechnology start-up founded by professors from The Chinese University of Hong Kong.
Delivery in Singapore: https://bit.ly/Lazada_SG_EN
Delivery in Malaysia: https://bit.ly/Lazada_MY_EN
The Uniqueness of G-NiiB Immunity+
- The first and only microbiome precision formula based on scientific data of COVID-19 patients.
- Immunity+ is clinically shown to be effective and safe in local novel virus patients.
- Researched and developed by The Chinese University of Hong Kong.
- Contains the 3+3 best ratio of live good bacteria and prebiotics based on the precise AI machine learning result
- Adopted patented microencapsulation technology from Italy ensures sufficient good live bacteria reach your intestine to deliver therapeutic actions and a long shelf-life.